FDA Inspection 1003825 — Robert Sing
The FDA completed an inspection of Robert Sing on Mar 3, 2017 in Charlotte, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 3, 2017
- Fiscal Year
- 2017
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Charlotte, NC (United States)
Additional Details
Clinical Investigator (CI)